Molecular and clinicopathological analysis of three cases of gastric juvenile polyposis

Yuya Yamashiro1, Yuka Yanai1, Tsutomu Takeda2

  • 1Department of Human Pathology Juntendo University School of Medicine Tokyo Japan.

Abstract

Insights

Juvenile polyposis (JP) involves SMAD4 mutations and carries a high cancer risk. Our study shows SMAD4 expression, even paradoxical, is linked to gastric JP dysplasia, suggesting other pathways drive malignancy.

Area of Science:

  • Gastroenterology
  • Oncology
  • Genetics

Background:

  • Juvenile polyposis (JP) is a rare condition linked to SMAD4/BMPR1A mutations.
  • JP has a significant risk of malignant transformation (9-50%), but carcinogenesis mechanisms are unclear.

Purpose of the Study:

  • To investigate the molecular mechanisms of malignant transformation in gastric Juvenile Polyposis.
  • To elucidate the role of SMAD4 and BMPR1A in the progression of gastric JP.

Main Methods:

  • Analyzed gastric polyps from three JP patients with varying atypia using immunohistochemistry, Sanger sequencing, and LOH analysis.
  • Focused on SMAD4, BMPR1A, and TP53 genes.

Main Results:

  • All three cases had SMAD4 germline mutations or strong suspicion thereof.
  • SMAD4 expression varied within lesions, with stronger nuclear expression in neoplastic areas, correlating with SMAD4 LOH status.
  • Paradoxical SMAD4 expression was observed even with biallelic SMAD4 inactivation.

Conclusions:

  • Strong nuclear SMAD4 expression, even if paradoxical, is associated with dysplastic polyps in gastric JP.
  • Complete SMAD4 inactivation is not essential for gastric JP polyp development.
  • Other molecular pathways likely contribute to the malignant phenotype in JP.

Related Concept Videos

Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
502
Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
285
Barrett Esophagus-I: Introduction01:21

Barrett Esophagus-I: Introduction

Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
190
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
785
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
191
Gastric Motility01:16

Gastric Motility

Gastric motility is the coordinated contraction and relaxation of stomach muscles that convert ingested food into chyme, a semi-liquid substance ready for further digestion in the intestines. The process begins with the vagus nerve inducing the relaxation of the smooth muscles in the fundus and body of the stomach, allowing these regions to expand and accommodate up to approximately 1.5 liters of food and liquid.
Peristaltic Waves and Chyme Formation
Upon food entry, the stomach initiates...
1.1K